AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON MAY 9, 2002
REGISTRATION NO. 333-81745
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
---------------------------------
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
----------
TRIANGLE PHARMACEUTICALS, INC.
(Exact name of Registrant as Specified in Its Charter)
Delaware 56-1930728
(State or Other Jurisdiction of (I.R.S. Employer
Incorporation or Organization) Identification No.)
----------
4 University Place,
4611 University Drive,
Durham, North Carolina, 27707
(919) 493-5980
(Address, Including Zip Code, and Telephone Number, Including Area Code,
of Registrant's Principal Executive Offices)
----------
Chris A. Rallis
President and Chief Operating Officer
TRIANGLE PHARMACEUTICALS, INC.
4 University Place,
4611 University Drive,
Durham, North Carolina 27707
(919) 493-5980
(Name, Address, Including Zip Code, and Telephone Number, Including Area
Code, of Agent for Service)
----------
COPY TO:
Rachel Mandell, Esq.
Senior Corporate Counsel
TRIANGLE PHARMACEUTICALS, INC.
4 University Place
4611 University Drive
Durham, North Carolina 27707
(919) 493-5980
----------
DEREGISTRATION OF SHARES
Triangle Pharmaceuticals is filing this post effective amendment to
deregister, as of the date hereof, 1,700,000 shares of Triangle Pharmaceuticals'
common stock remaining unsold at the conclusion of the offering described in the
registration statement on Form S-3 (Reg. No. 333-81745). The shares were being
offered by selling stockholders of Triangle Pharmaceuticals.
SIGNATURES
Pursuant to the requirements of the Securities Act, the Registrant
certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form S-3 and has duly caused this Registration
Statement to be signed on its behalf by the undersigned, thereunto duly
authorized, in the City of Durham, State of North Carolina, on the 9th day of
May, 2002.
TRIANGLE PHARMACEUTICALS, INC.
By: /s/ Chris A. Rallis
---------------------------------------
Chris A. Rallis
President and Chief Operating Officer
Pursuant to the requirements of the Securities Act, this Registration
Statement has been signed by the following persons in the capacities and on the
dates indicated:
Signature Title
--------- -----
/s/ Chris A. Rallis Director, President and Chief Operating Officer May 9, 2002
--------------------------------------- (Principal Executive Officer)
Chris A. Rallis
/s/ Robert F. Amundsen, Jr. Executive Vice President and Chief Financial May 9, 2002
--------------------------------------- Officer (Principal Financial and Accounting
Robert F. Amundsen, Jr. Officer)
/s/ Anthony B. Evnin Director May 9, 2002
---------------------------------------
Anthony B. Evnin
/s/ Standish M. Fleming Director May 9, 2002
---------------------------------------
Standish M. Fleming
/s/ Dennis B. Gillings Director May 9, 2002
---------------------------------------
Dennis B. Gillings
/s/ Henry G. Grabowski Director May 9, 2002
---------------------------------------
Henry G. Grabowski
/s/ Stewart J. Hen Director May 9, 2002
---------------------------------------
Stewart J. Hen
/s/ Jonathan S. Leff Director May 9, 2002
---------------------------------------
Jonathan S. Leff
/s/ George McFadden Director May 9, 2002
---------------------------------------
George McFadden
/s/ James L. Tyree Director May 9, 2002
---------------------------------------
James L. Tyree